C5a
Overview[edit | edit source]
C5a is a potent anaphylatoxin and a key component of the complement system, which is part of the innate immune system. It is a 74-amino acid glycoprotein fragment derived from the cleavage of the complement component C5 by the enzyme C5 convertase. C5a plays a crucial role in the inflammatory response and has various biological activities, including chemotaxis, cell activation, and modulation of immune responses.
Structure[edit | edit source]
C5a is a small protein with a molecular weight of approximately 11 kDa. It is composed of a single polypeptide chain that forms a compact, globular structure stabilized by three disulfide bonds. The structure of C5a includes a helical region and a flexible C-terminal tail, which is critical for its interaction with the C5a receptor (C5aR).
Function[edit | edit source]
C5a is primarily known for its role as an anaphylatoxin, which means it can induce rapid degranulation of mast cells and basophils, leading to the release of histamine and other inflammatory mediators. This contributes to increased vascular permeability and smooth muscle contraction, which are characteristic of anaphylactic reactions.
Chemotaxis[edit | edit source]
C5a is a powerful chemotactic agent, attracting neutrophils, monocytes, eosinophils, and macrophages to sites of infection or tissue damage. This recruitment of immune cells is essential for the clearance of pathogens and the resolution of inflammation.
Cell Activation[edit | edit source]
C5a can activate various cell types, including endothelial cells, smooth muscle cells, and leukocytes. Upon binding to its receptor, C5aR, on these cells, it triggers intracellular signaling pathways that lead to the production of pro-inflammatory cytokines, upregulation of adhesion molecules, and enhanced phagocytic activity.
Immune Modulation[edit | edit source]
C5a modulates the immune response by influencing the balance between pro-inflammatory and anti-inflammatory signals. It can enhance the production of interleukin-1 (IL-1), tumor necrosis factor-alpha (TNF-α), and other cytokines, while also promoting the clearance of apoptotic cells and debris.
Receptors[edit | edit source]
C5a exerts its effects through binding to specific receptors on target cells. The primary receptor for C5a is the C5a receptor (C5aR, also known as CD88), a G protein-coupled receptor expressed on various immune and non-immune cells. A second receptor, C5L2 (also known as GPR77), has been identified, but its role in C5a signaling is less well understood.
Clinical Significance[edit | edit source]
C5a is implicated in a variety of pathological conditions due to its potent pro-inflammatory effects. It is involved in the pathogenesis of sepsis, autoimmune diseases, and allergic reactions. Therapeutic targeting of C5a or its receptors is an area of active research, with the aim of modulating excessive inflammatory responses in these conditions.
Sepsis[edit | edit source]
In sepsis, excessive activation of the complement system and overproduction of C5a can lead to systemic inflammation, tissue damage, and organ failure. Inhibitors of C5a or C5aR are being investigated as potential treatments to reduce the inflammatory burden in septic patients.
Autoimmune Diseases[edit | edit source]
C5a contributes to the pathogenesis of several autoimmune diseases, including rheumatoid arthritis and systemic lupus erythematosus. By promoting the recruitment and activation of inflammatory cells, C5a exacerbates tissue damage and autoimmunity.
Allergic Reactions[edit | edit source]
As an anaphylatoxin, C5a plays a role in allergic reactions by inducing mast cell degranulation and histamine release. Modulating C5a activity may help in managing allergic conditions.
Research and Therapeutics[edit | edit source]
Research into C5a and its receptors has led to the development of various therapeutic agents aimed at modulating its activity. These include monoclonal antibodies, small molecule inhibitors, and receptor antagonists. Such therapies hold promise for treating inflammatory and autoimmune diseases by dampening the excessive immune response mediated by C5a.
Conclusion[edit | edit source]
C5a is a critical mediator of inflammation and immune responses, with significant roles in both physiological and pathological processes. Understanding its mechanisms of action and interactions with receptors is essential for developing targeted therapies for inflammatory diseases.
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD